Kidney Cancer Trial, Recruiting (NCT03981497)

Kidney Cancer Trial, Recruiting NCT03981497 Sponsor: Francesco De Cobelli Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03981497 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults over 18 years old who have primary (originating in the liver) or secondary (spread to the liver from elsewhere) liver tumours, or small kidney tumours, where surgery is not possible or cannot fully remove the tumour
People with primary liver cancer who have up to three tumour nodules, each no larger than 3 cm
People with secondary liver tumours who have nodules no larger than 3 cm, where the goal is to completely clear all tumours from the liver
People with kidney tumours smaller than 4 cm, including those with single or multiple tumours (such as those with a condition called von Hippel-Lindau syndrome)

Who may not be able to join:

Women who are pregnant
People with blood clotting problems that cannot be managed or controlled
People whose cancer has spread extensively beyond the liver or kidney
People being considered for liver treatment who have had a surgical connection made between the bile ducts and the digestive system (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390226432529

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03981497

Sponsor: Francesco De Cobelli

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +390226432529

More information: https://clinicaltrials.gov/study/NCT03981497

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults over 18 years old who have primary (originating in the liver) or secondary (spread to the liver from elsewhere) liver tumours, or small kidney tumours, where surgery is not possible or cannot fully remove the tumour
People with primary liver cancer who have up to three tumour nodules, each no larger than 3 cm
People with secondary liver tumours who have nodules no larger than 3 cm, where the goal is to completely clear all tumours from the liver
People with kidney tumours smaller than 4 cm, including those with single or multiple tumours (such as those with a condition called von Hippel-Lindau syndrome)

Who may not be able to join:

Women who are pregnant
People with blood clotting problems that cannot be managed or controlled
People whose cancer has spread extensively beyond the liver or kidney
People being considered for liver treatment who have had a surgical connection made between the bile ducts and the digestive system (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Francesco De Cobelli

Registry

ClinicalTrials.gov

Start date

28 February 2018

Est. completion

31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Local Tumor Progression Free Survival; Time to Local Progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov